OVERVIEW | ADVISORY ACTIVITIES | CAPITAL FORMATION | MANAGEMENT TEAM | CONTACT US
  TRANSACTIONS:Healthcare | Marketing Services, Media & Technology | Finance & Real Estate | Tombstones


Our healthcare related advisory transactions have included:

Pharma/wHealth Fund (Luxembourg Stock Exchange)
    • » In conjunction with Bank Sal Oppenheim jr. & Cie. (now wholly-owned by Deutsche Bank) structured this open-end healthcare fund in 1993. The Fund has ranged in size from $100 million to $600 million and has generated annualized better than 10% in its initial 20 years. We continue to provide advice regarding strategy, portfolio management, manager selection, marketing and reporting.
    • » Board of Directors

Centerpulse (Swiss Stock Exchange)
    • » Helped negotiate settlement with U.S. plaintiffs on behalf of Swiss shareholders.
    • » Advised in selecting the optimal banking team and the structuring and execution of $850 million global debt and equity financing.
    • » Advised in the sale of Centerpulse to Zimmer for CHF 4.8 billion in 2003.
    • » Sale resulted from first ever successful hostile takeover bid in Switzerland.
    • » Transaction was named "The 2003 Healthcare Deal of the Year" by Investment Dealers Digest.

Frankel Group, Inc. (N.Y. and Cambridge, MA - Private)
    • » Advised this Life Science Strategy Consultancy on ownership options resulting in recommendation not to sell.

Medical Device Company (European - Private)
    • » Advised on global commercial and technology license arrangements.

Medical Device Company (European - Private)
    • » Advised on the sale of family owned business.

Physicians' Weekly (U.S. - Private)
    • » Initiated, negotiated and closed sale to Healthway Communications International.

Private Equity Vehicle (European - Private)
    • » Structured off-shore biotechnology private equity investment vehicle for wealthy family.
    • » Board of Directors

The healthcare related private equity investment activities by our clients, our affiliates and us include:

    • » Pharma/wHealth - Europe
    • » Amylin Pharmaceuticals, Inc. - U.S.
    • » Axxima Pharmaceuticals AG - Europe
    • » Biota Holdings Limited - Australia
    • » Cadus Pharmaceuticals, Inc. - U.S.
    • » Caliper Life Sciences - U.S.
    • » Conceptis Technologies Inc. - U.S.
    • » Geneprot Inc. - U.S.
    • » Health Hero Network, Inc. - U.S.
    • » Lynx Therapeutics, Inc. - U.S.
    • » Memory Pharmaceuticals Corp. - U.S.
    • » Ontogeny, Inc. - U.S.
    • » Orchid BioSciences, Inc. - U.S.
    • » Peptimmune, Inc. - U.S.
    • » Physiome Sciences, Inc. - U.S.
    • » PrediX Pharmaceuticals, Inc. - Israel
    • » Precept Inc. - U.S.
    • » Signal Pharmaceuticals Inc. - U.S.
    • » Structural Genomix, Inc. - U.S.
    • » SWITCH Biotech AG - Europe
    • » Tularik Inc. - U.S.
    • » Valentis lnc. - U.S.

Back to Top
Copyright © 2013 Mesco Ltd. All rights reserved.